TP53 and cholangiocarcinoma: Lowery et al. tested 195 samples of CCA, highlighting that the most frequently altered genes in CCA were IDH1 (30%), ARID1A (23%), BAP1 (20%), TP53 (20%), and FGFR2 gene fusions (14%) [55].